Go to the list of all blogs
Allana's Avatar
published in Blogs
Jul 25, 2026
Oracle Corporation (ORCL) Shares Drop 24.6% as AI Capex Concerns Intensify

Oracle Corporation (ORCL) Shares Drop 24.6% as AI Capex Concerns Intensify

Key Takeaways

  • Oracle shares have fallen 24.6% over the past 30 days, plunging from $152.46 on June 25 to $114.99 on July 24, hitting fresh 52-week lows.
  • The sell-off accelerated after S&P Global Ratings downgraded Oracle's credit rating to BBB- on July 9, one notch above junk status, citing unsustainable AI infrastructure spending.
  • Fiscal 2026 free cash flow reached negative $23.7 billion as capital expenditures swelled to $55.7 billion, and management guided for up to $95 billion in fiscal 2027 capex.
  • Despite the stock's collapse, Oracle's underlying business remains strong: fiscal 2026 revenue rose 17% to $67.4 billion, and remaining performance obligations hit a record $638 billion.
  • Wall Street analysts remain largely bullish, with an average price target near $248 — more than double the current share price — though concentration risk tied to OpenAI commitments remains a key concern.

Oracle Corporation (ORCL) Company Overview and Market Position

Oracle Corporation is one of the world's largest enterprise technology companies, best known for its database management systems, enterprise resource planning software, and rapidly expanding cloud infrastructure business. Founded in 1977 and headquartered in Austin, Texas, Oracle has spent the last several years pivoting from its legacy on-premise software model toward cloud-based services, competing directly with hyperscale cloud providers including AMZN, MSFT, and GOOGL. The company's Oracle Cloud Infrastructure (OCI) segment has become a central player in the artificial intelligence infrastructure race, securing multi-billion-dollar contracts with AI developers including OpenAI. Oracle's competitive advantage rests on its entrenched enterprise customer relationships, high-performance database technology, and a multi-cloud strategy that increasingly positions OCI as an AI-training and inference alternative to the Big Three cloud vendors. Investors track ORCL closely as both a legacy software bellwether and an emerging AI infrastructure contender. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Oracle Corporation (ORCL) Stock Price Performance: Last 30 Days vs. Quarter

Over the last 30 calendar days, Oracle shares have tumbled 24.6%, declining from a closing price of $152.46 on June 25, 2026, to $114.99 at the close on July 24. The stock touched a fresh 52-week low of $114.75 during the final session of the period, marking its lowest level in more than two years. Trading volumes have consistently run above the 90-day average, indicating elevated institutional selling pressure rather than routine drift.

Zooming out to a quarterly view, the decline is even more dramatic. Oracle traded near $173 at the end of April and surged to an intra-quarter peak of $248.15 on June 1 following strong fiscal fourth-quarter results. From that peak, the stock has shed approximately 54% of its value — an extraordinary reversal within a single quarter. The broader multi-month trend reflects a market-wide reassessment of AI infrastructure spending, with Oracle at the epicenter due to its aggressive capital expenditure commitments relative to its balance sheet capacity. From what I see, this kind of sharp reversal often signals deeper shifts in how the market values growth versus risk.

What Drove ORCL Stock Price in the Last 30 Days

The sharp 30-day decline has been fueled by a cascade of negative developments centered on Oracle's balance sheet and the scale of its AI-related spending. On July 9, S&P Global Ratings downgraded Oracle's long-term credit rating from BBB to BBB-, leaving the company just one notch above speculative-grade territory. S&P explicitly cited the enormous cost of Oracle's AI data center build-out, projecting fiscal 2027 capital expenditures of $90 billion to $95 billion and a free operating cash flow deficit widening to approximately $42 billion. Oracle's five-year credit default swap spreads subsequently surged to their highest levels in nearly 18 years.

Compounding the credit concerns, a New Mexico regulator again rejected a pipeline permit critical to powering Oracle's flagship Project Jupiter data center, threatening construction timelines. Separately, reports of a potential Clop ransomware group intrusion surfaced in mid-July, raising cybersecurity and reputational risks. Additionally, Oracle confirmed plans to raise approximately $40 billion through debt and equity financing in fiscal 2027, including a $20 billion share issuance that will dilute existing shareholders. These developments landed on a stock already reeling from broader AI capex anxiety, as investors across the sector began questioning whether enormous infrastructure investments will generate adequate returns. I also checked this using Tickeron’s AI Pattern Search Engine to review similar historical setups.

What Drove ORCL Stock Performance Over the Last Quarter

Oracle's quarterly journey tells a story of dramatic reversal. The stock initially surged in late May and early June after the company reported fiscal fourth-quarter results that exceeded expectations: revenue of $19.2 billion, up 21% year over year, with cloud infrastructure revenue soaring 93% to $5.8 billion. Remaining performance obligations reached $638 billion — up an extraordinary 363% from the prior year. The market briefly priced Oracle as a premier AI winner, pushing shares near $250.

That narrative cracked almost immediately once investors absorbed the full cost picture. The same earnings release revealed that fiscal 2026 capital expenditures had consumed all of the company's record $32 billion in operating cash flow, producing negative free cash flow of $23.7 billion. With management guiding for even higher spending in fiscal 2027 and S&P's subsequent downgrade validating balance-sheet fears, the market rapidly repriced Oracle from an AI growth story to a credit-risk story. The stock's 54% decline from its quarterly peak reflects a profound shift in sentiment: revenue growth and backlog metrics that once commanded premium multiples are now being viewed through the lens of debt sustainability and dilution risk.

ORCL Stock Forecast Drivers: What Investors Should Watch Next

Several factors will determine Oracle's trajectory from here. First, the company's planned $20 billion equity issuance — and the terms at which it prices — will be a critical test of institutional demand and could set a near-term floor or ceiling for the stock. Second, quarterly updates on remaining performance obligation conversion rates will reveal whether the $638 billion backlog is translating into revenue on schedule, particularly the portion tied to OpenAI. Third, any additional rating agency actions from Moody's, which already maintains a negative outlook on Oracle, could pressure borrowing costs further.

On the operational side, resolution of the New Mexico pipeline dispute for Project Jupiter and progress on the Stargate data center in Texas will serve as bellwethers for execution capability. Broader macro developments — including interest rate policy, AI enterprise adoption trends, and competitive dynamics among hyperscale cloud providers — will also shape sentiment. With Oracle trading at roughly 14 to 16 times forward adjusted earnings, the stock's valuation now embeds significant skepticism; the gap between the current price and the average analyst target of approximately $248 underscores the importance of upcoming quarterly data in resolving whether the market's fears or the backlog's promise proves more accurate. I'm watching this closely as the next earnings release could clarify the path forward.

Exploring AI-Powered Trading Approaches

In volatile environments like the one ORCL is navigating, I find it useful to look at systematic strategies alongside fundamental analysis. Tickeron’s Trending AI Robots page highlights top-performing AI-driven trading bots across various timeframes and risk profiles. It offers a practical way to review performance metrics and methodologies that complement traditional research when markets shift quickly.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ORCL

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


ORCL's RSI Indicator ascending out of oversold territory

The RSI Indicator for ORCL moved out of oversold territory on July 27, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 29 similar instances when the indicator left oversold territory. In of the 29 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 30, 2026. You may want to consider a long position or call options on ORCL as a result. In of 70 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ORCL just turned positive on July 22, 2026. Looking at past instances where ORCL's MACD turned positive, the stock continued to rise in of 37 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where ORCL advanced for three days, in of 337 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ORCL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ORCL broke above its upper Bollinger Band on August 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ORCL entered a downward trend on August 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.751) is normal, around the industry mean (24.057). P/E Ratio (26.292) is within average values for comparable stocks, (74.273). Projected Growth (PEG Ratio) (0.866) is also within normal values, averaging (1.911). Dividend Yield (0.013) settles around the average of (0.021) among similar stocks. P/S Ratio (6.631) is also within normal values, averaging (134.061).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ORCL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ORCL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are Microsoft Corp (NASDAQ:MSFT), Oracle Corp (NYSE:ORCL), Palo Alto Networks Inc (NASDAQ:PANW), Crowdstrike Holdings Inc (NASDAQ:CRWD), Block Inc (NYSE:XYZ), NetApp (NASDAQ:NTAP), Twilio (NYSE:TWLO), MongoDB (NASDAQ:MDB), Zscaler (NASDAQ:ZS), Okta (NASDAQ:OKTA).

Industry description

Computer communications industry develops technology that allows computing devices to exchange data with each other using connections/data links between nodes. Common types of computer network include Cloud (IAN), Internet, Wide (WAN, Local (LAN)/Wireless(WLAN) etc. The industry is an ever-more important part of technology, and is set to become even bigger as the Internet of Things (IoT) rapidly forays into the various aspects of our lives. Cisco Systems, Inc., Palo Alto Networks, Inc. and Arista Networks, Inc., Fortinet, Inc. are some of the major computer communications companies.

Market Cap

The average market capitalization across the Computer Communications Industry is 35.26B. The market cap for tickers in the group ranges from 48.8K to 3.66T. MSFT holds the highest valuation in this group at 3.66T. The lowest valued company is WMHI at 48.8K.

High and low price notable news

The average weekly price growth across all stocks in the Computer Communications Industry was 2%. For the same Industry, the average monthly price growth was 1%, and the average quarterly price growth was 25%. AIFA experienced the highest price growth at 65%, while GYGY experienced the biggest fall at -33%.

Volume

The average weekly volume growth across all stocks in the Computer Communications Industry was -28%. For the same stocks of the Industry, the average monthly volume growth was 2% and the average quarterly volume growth was -65%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 72
Price Growth Rating: 56
SMR Rating: 80
Profit Risk Rating: 91
Seasonality Score: -4 (-100 ... +100)
View a ticker or compare two or three
ORCL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of a diversified line of business software products

Industry ComputerCommunications

Profile
Details
Industry
Packaged Software
Address
2300 Oracle Way
Phone
+1 737 867-1000
Employees
164000
Web
https://www.oracle.com
Interact to see
Advertisement
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.